WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Operating Expenses
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Operating Expenses of $1.16 million for the 3-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for the quarter ending 2012-09-30 was $1.16M, a 84.38% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for the quarter ending 2012-06-30 was $3.49M, a 24.78% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for the quarter ending 2012-03-31 was $1.25M, a 50.18% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for the quarter ending 2011-12-31 was $2.74M, a 27.70% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for fiscal 2011 was $17.30M, a 52.57% increase from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating expenses for fiscal 2010 was $11.34M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2012-09-30 | $1.16M 10-Q/A · filed 2012-12-11 | $4.65M derived: sum of 2 quarters · filed 2012-12-11 | $5.90M 10-Q/A · filed 2012-12-11 | $8.64M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-06-30 | $3.49M 10-Q/A · filed 2012-08-30 | $4.75M 10-Q/A · filed 2012-08-30 | $7.48M derived: sum of 3 quarters · filed 2012-08-30 | $14.89M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-03-31 | $1.25M 10-Q · filed 2012-05-15 | $3.99M derived: sum of 2 quarters · filed 2012-05-15 | $11.39M derived: sum of 3 quarters · filed 2012-12-11 | $16.04M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-12-31 | $2.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $10.14M derived: sum of 2 quarters · filed 2012-12-11 | $14.78M derived: sum of 3 quarters · filed 2012-12-11 | $17.30M 10-K · filed 2012-03-30 |
| 2011-09-30 | $7.40M 10-Q/A · filed 2012-12-11 | $12.05M derived: sum of 2 quarters · filed 2012-12-11 | $14.56M 10-Q/A · filed 2012-12-11 | $18.35M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | $4.65M 10-Q/A · filed 2012-08-30 | $7.16M 10-Q/A · filed 2012-08-30 | $10.95M derived: sum of 3 quarters · filed 2012-08-30 | $13.28M derived: sum of 4 quarters · filed 2012-08-30 |
| 2011-03-31 | $2.51M 10-Q · filed 2012-05-15 | $6.30M derived: sum of 2 quarters · filed 2012-05-15 | $8.64M derived: sum of 3 quarters · filed 2012-05-15 | $11.90M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $6.12M derived: sum of 2 quarters · filed 2012-03-30 | $9.39M derived: sum of 3 quarters · filed 2012-03-30 | $11.34M 10-K · filed 2012-03-30 |
| 2010-09-30 | $2.34M 10-Q · filed 2011-11-21 | $5.60M derived: sum of 2 quarters · filed 2011-11-21 | $7.55M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $3.26M 10-Q/A · filed 2011-09-01 | $5.21M 10-Q/A · filed 2011-09-01 |